Oxford Cannabinoid Technologies Holdings' CEO is Clarissa Sowemimo-Coker, appointed in Dec 2022, has a tenure of 1.67 years. total yearly compensation is £215.67K, comprised of 90% salary and 10% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $7.00K. The average tenure of the management team and the board of directors is 1.7 years and 2.3 years respectively.
Key information
Clarissa Sowemimo-Coker
Chief executive officer
UK£215.7k
Total compensation
CEO salary percentage
90.03%
CEO tenure
1.7yrs
CEO ownership
0.2%
Management average tenure
1.7yrs
Board average tenure
2.3yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Clarissa Sowemimo-Coker's remuneration changed compared to Oxford Cannabinoid Technologies Holdings's earnings?
Date
Total Compensation
Salary
Company Earnings
Oct 31 2023
n/a
n/a
-UK£4m
Jul 31 2023
n/a
n/a
-UK£5m
Apr 30 2023
UK£216k
UK£194k
-UK£6m
Apr 30 2022
UK£194k
UK£174k
-UK£5m
May 31 2021
n/a
n/a
-UK£3m
Compensation vs Market: Clarissa's total compensation ($USD276.25K) is below average for companies of similar size in the US market ($USD683.56K).
Compensation vs Earnings: Clarissa's compensation has increased whilst the company is unprofitable.
CEO
Clarissa Sowemimo-Coker (44 yo)
1.7yrs
Tenure
UK£215,669
Compensation
Ms. Clarissa Ann Sowemimo-Coker serves as Chief Executive Officer at Oxford Cannabinoid Technologies Holdings Plc since April 12, 2023 and is its Executive Director since February 4, 2021. She was its Comp...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Clarissa Sowemimo-Coker
CEO & Executive Director
1.7yrs
UK£215.67k
0.23% $ 7.0k
Indraneil Mahapatra
Co-Founder & Non-Executive Director
no data
UK£25.00k
1.96% $ 59.8k
Paul Smalley
Finance Director & Executive Director
1.8yrs
UK£155.16k
no data
Valentino Parravicini
Chief Scientific Officer
4.1yrs
no data
no data
Robin Bennett
General Counsel & Company Secretary
1.7yrs
no data
0.030% $ 926.8
Timothy Corn
Executive Director & Chief Medical Officer
1.2yrs
no data
no data
1.7yrs
Average Tenure
51yo
Average Age
Experienced Management: OCTH.F's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
Name
Position
Tenure
Compensation
Ownership
Clarissa Sowemimo-Coker
CEO & Executive Director
3.5yrs
UK£215.67k
0.23% $ 7.0k
Indraneil Mahapatra
Co-Founder & Non-Executive Director
3.5yrs
UK£25.00k
1.96% $ 59.8k
Paul Smalley
Finance Director & Executive Director
1.8yrs
UK£155.16k
no data
Timothy Corn
Executive Director & Chief Medical Officer
less than a year
no data
no data
Julie Pomeroy
Independent Non-Executive Chair
3.3yrs
UK£45.00k
0.060% $ 1.8k
Robert Dworkin
Member of Scientific Advisory Board
2.3yrs
no data
no data
Charanjit Dhillon
Senior Independent Non-Executive Director
3.3yrs
UK£25.00k
no data
Giorgio Lambru
Member of Scientific Advisory Board
2.3yrs
no data
no data
Anthony Dickenson
Member of Scientific Advisory Board
2.3yrs
no data
no data
Darren Mott
Independent Non-Executive Director
less than a year
no data
no data
William Farquhar-Smith
Member of Scientific Advisory Board
no data
no data
no data
2.3yrs
Average Tenure
51yo
Average Age
Experienced Board: OCTH.F's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/08/05 19:23
End of Day Share Price
2024/05/08 00:00
Earnings
2023/10/31
Annual Earnings
2023/04/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Oxford Cannabinoid Technologies Holdings Plc is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.